文献速递血栓与止血

因子XI缺乏与心血管事件及静脉血栓栓塞事件风险降低相关

Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events.
PubMed 文献 · Blood · 2016-12-30

这项历史性队列研究利用以色列Clalit健康服务电子数据库,纳入2002至2014年间检测因子XI活性的10193名成人,按活性分为正常(>50%)、轻度缺乏(30%-50%)和中重度缺乏(≤30%)三组,随访至2015年12月31日。与活性正常者相比,轻度缺乏者心血管事件调整HR为0.52(95%CI 0.31-0.87),中重度缺乏者为0.57(95%CI 0.35-0.93);因子XI缺乏(活性<50%)者VTE发生率更低,调整HR=0.26(95%CI 0.08-0.84)。

要点

  • 因子XI缺乏者心血管事件风险低于活性正常者,轻度缺乏调整HR 0.52,中重度缺乏调整HR 0.57。
  • 因子XI缺乏(活性<50%)者静脉血栓栓塞风险更低,调整HR=0.26。
  • 研究基于以色列大型医疗数据库的历史性队列,共纳入10193名成人。

核心结论

  • 因子XI缺乏与心血管事件及静脉血栓栓塞事件发生率降低相关。

研究设计与样本

  • 历史性队列研究,使用以色列最大医疗服务提供者Clalit健康服务的电子数据库。
  • 纳入2002至2014年间检测因子XI活性的所有成人,随访至2015年12月31日。
  • 共纳入10193名患者,按因子XI活性分为正常(>50%)、轻度缺乏(30%-50%)和中重度缺乏(≤30%)三组。

主要发现

  • 8958名(88.9%)因子XI活性正常,690名(6.8%)轻度缺乏,542名(5.3%)中重度缺乏。
  • 与活性正常者相比,轻度缺乏者心血管事件调整HR为0.52(95%CI 0.31-0.87),中重度缺乏者为0.57(95%CI 0.35-0.93)。
  • 因子XI缺乏(活性<50%)者VTE发生率低于活性正常者,调整HR=0.26(95%CI 0.08-0.84)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Factor XI deficiency is one of the rare inherited coagulation factor deficiencies. However, its incidence is high within the Ashkenazi Jewish community. Because factor XI displays both procoagulant and antifibrinolytic activities, it has been postulated that an underlying cardiovascular benefit may exist with factor XI deficiency. This historical cohort study was performed using the electronic database of Clalit Health Services, the largest health care provider in Israel. All adults tested for factor XI activity between 2002 and 2014 were included in the study. Factor XI activity was classified into 3 categories: normal (activity >50%), mild deficiency (activity = 30%-50%), and moderate-severe deficiency (activity ≤30%). The cohort was followed until 31 December 2015 for incidence of cardiovascular events (composite of myocardial infarction, stroke, and transient ischemic attack) and venous thromboembolism (VTE). Of the 10 193 included patients, 8958 (88.9%) had normal factor XI activity, 690 (6.8%) had mild deficiency, and 542 (5.3%) had moderate-severe deficiency. Compared with individuals with normal activity, the adjusted hazard ratio (HR) for cardiovascular events was 0.52 (95% confidence interval [CI], 0.31-0.87) in those with mild deficiency, and 0.57 (95% CI, 0.35-0.93) in those with moderate-severe factor XI deficiency. The incidence of VTE was lower in those with factor XI deficiency (activity <50%) compared with those with normal activity; adjusted HR = 0.26 (95% CI, 0.08-0.84). In summary, factor XI deficiency is associated with decreased incidence of cardiovascular events and VTE.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Preis M, Hirsch J, Kotler A, et al. Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events. Blood. 2016. PMID: 28039189. doi:10.1182/blood-2016-09-742262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。